Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
kinase inhibitor
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...